Sodium Iodide → 5-Benzyl-3-methyl-6-propyl-5H-isoxazolo[5,4-d]pyrimidin-4-one

HRID 1794592Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1794592
[CH3:1][C:2]1[C:10]2[C:9](=[O:11])[NH:8][C:7]([CH2:12][CH2:13][CH3:14])=[N:6][C:5]=2[O:4][N:3]=1.C[Si](C)(C)[N-][Si](C)(C)C.[Li+].[CH2:25](Br)[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1.[Na+].[I-]>C1COCC1>[CH2:25]([N:8]1[C:9](=[O:11])[C:10]2[C:2]([CH3:1])=[N:3][O:4][C:5]=2[N:6]=[C:7]1[CH2:12][CH2:13][CH3:14])[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1

Komponenten

6

Versuchsvorschrift

A suspension of the compound of Example 1 Step 2 (1.8 g, 9.3 mmol) in anhydrous THF (40 mL) at room temperature was treated with 1M lithium hexamethyldisilazide (13.9 mL, 13.9 mmol) and stirred for 1 h. The mixture was then treated with benzylbromide (2.37 g, 1.65 mL, 13.9 mmol) and NaI (0.15 g, 1.0 mmol). The mixture was stirred at 50° C. for 40 h, then cooled to room temperature. The mixture was partitioned between ether and brine and the organic phase was washed with water. The organic phase was concentrated under vacuum and purified by flash chromatography on SiO2 (15% EtOAc/Hexane) to afford the desired product as a white solid (540 mg, 20%); 1H NMR (DMSO-d6) δ 7.35 (m, 5H), 5.41 (s, 2H), 2.79 (t, J=7.5 Hz, 2H), 2.53 (s, 3H), 1.72 (q, J=7.5 Hz, 2H), 0.90 (t, J=7.5 Hz, 3H); LC/MS (ESI): 284 (M+H)+.

Aufarbeitung

  1. stirringThe mixture was stirred at 50° C. for 40 h
  2. customThe mixture was partitioned between ether and brine
  3. washthe organic phase was washed with water
  4. concentrationThe organic phase was concentrated under vacuum
  5. custompurified by flash chromatography on SiO2 (15% EtOAc/Hexane)

Quellen und Nachweise

ORD-Eintrag
ord-e928a16e775a45678529cce43f19dad0
Quelldatensatz
uspto-grants-2006_04
Patentnummer
US07022850B2

Notizen zur Reaktion

Wird geladen…